Healthcare Triangle is trading at $0.51, down 10.32%, as the October 8, 2026 deadline to appeal Nasdaq’s delisting determination arrives.
- Nasdaq found the company below its $1 minimum bid-price requirement; prior reverse splits make it ineligible for the usual compliance period.
- Without an appeal, trading could be suspended at the October 12 open. The company previously said it intended to request a hearing.
- No trading-volume figures were available in the cited sources.